Press Release: Mercator MedSystems : Mercator MedSystems Announces Publication of Results from TANGO Phase 2 Clinical Trial to Improve Outcomes after Below-Knee Arterial Revascularization

First U.S. Double-Blinded Randomized Controlled Trial to Date Addressing Unmet Needs in Critical Limb IschemiaSAN LEANDRO, CA / ACCESSWIRE / November 3, 2022 / Mercator MedSystems, Inc. ("Mercator"), a medical technology company specializing in local drug delivery, announced today that their data from the TANGO (Temsirolimus adventitial delivery to improve ANGiographic Outcomes below the knee) Phase 2 trial has been published in the Journal ...